Wegovy 1mg injection contains semaglutide and is used alongside a reduced-calorie diet and exercise for chronic weight management in adults and adolescents aged 12 and older with obesity, or overweight individuals with weight-related health problems. It is also used to lower the risk of major cardiovascular events like heart attacks and stroke in adults with known heart disease and excess weight.Primary UsesLong-Term Weight Control: Helps reduce and maintain body weight by mimicking the GLP-1 hormone to curb appetite, lower food cravings, and increase fullness.Cardiovascular Risk Reduction: Lowers the chances of major adverse cardiac events (such as cardiovascular death, non-fatal heart attack, or stroke) in adults with heart disease and obesity or overweight.Dose Escalation Step: The 1mg dose acts as an intermediate maintenance or titration step in the multi-month dosage increase schedule (moving up from lower doses toward the target 2.4mg maintenance dose) to help reduce stomach-related side effects.How It WorksActs like the natural GLP-1 hormone to target areas of the brain that control appetite.Slows down stomach digestion so you feel full faster and longer after eating.Common Side EffectsNausea and vomitingDiarrhea or constipationStomach pain or upset stomachHeadache and fatigue1mg